| Literature DB >> 32439010 |
Leslie Cho1, Melinda Davis2, Islam Elgendy3, Kelly Epps4, Kathryn J Lindley5, Puja K Mehta6, Erin D Michos7, Margo Minissian8, Carl Pepine9, Viola Vaccarino10, Annabelle Santos Volgman11.
Abstract
Cardiovascular disease (CVD) remains the leading cause of morbidity and mortality for women in the United States and worldwide. There has been no American College of Cardiology (ACC)/American Heart Association guideline update specifically for the prevention of CVD in women since 2011. Since then, the body of sex-specific data has grown, in addition to updated hypertension, cholesterol, diabetes, atrial fibrillation, and primary prevention guidelines. The ACC CVD in Women Committee undertook a review of the recent guidelines and major studies to summarize recommendations pertinent to women. In this update, the authors address special topics, particularly the risk factors and treatments that have led to some controversies and confusion. Specifically, sex-related risk factors, hypertension, diabetes, hyperlipidemia, anticoagulation for atrial fibrillation, use of aspirin, perimenopausal hormone therapy, and psychosocial issues are highlighted.Entities:
Keywords: adverse pregnancy outcomes; aspirin; atrial fibrillation; cardiovascular disease; gestational diabetes
Mesh:
Year: 2020 PMID: 32439010 PMCID: PMC8328156 DOI: 10.1016/j.jacc.2020.03.060
Source DB: PubMed Journal: J Am Coll Cardiol ISSN: 0735-1097 Impact factor: 24.094